Spero therapeutics to provide business update and report fourth quarter and full-year 2020 financial results on thursday, march 11, 2021

Cambridge, mass., march 03, 2021 (globe newswire) -- spero therapeutics, inc. (nasdaq: spro), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that it will host a conference call and live audio webcast on march 11, 2021 at 4:30 p.m. est to report its fourth quarter and full-year 2020 financial results and provide an update on its business and pipeline.
SPRO Ratings Summary
SPRO Quant Ranking